Eversept Partners, LP Infla Rx N.V. Transaction History
Eversept Partners, LP
- $1.33 Billion
- Q1 2024
A detailed history of Eversept Partners, LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Eversept Partners, LP holds 1,305,140 shares of IFRX stock, worth $2.27 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,305,140
Previous 1,305,140
-0.0%
Holding current value
$2.27 Million
Previous $2.13 Million
5.55%
% of portfolio
0.15%
Previous 0.21%
Shares
11 transactions
Others Institutions Holding IFRX
# of Institutions
40Shares Held
13.8MCall Options Held
12.9KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$9.98 Million0.38% of portfolio
-
Citigroup Inc1.2MShares$2.09 Million0.0% of portfolio
-
Morgan Stanley New York, NY979KShares$1.7 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY870KShares$1.51 Million0.11% of portfolio
-
Tang Capital Management LLC San Diego, CA769KShares$1.34 Million0.14% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $76.9M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...